Warning-letter response · Delivered
Demo brand
Claims section signed · with counsel · latest scan Oct 3, 2026
Claims section signed · with counsel
Claims the letter quotes
86 Critical
6 Critical · 2 High · 0 Medium
Category rank
#11+129
Of 194 Immune listings · 1 is riskiest
AI answers
1 / 61 flagged
6 assistants asked as a shopper would
Sample data.
Since you last lookedSample visit, 27 Sep
Your warning letter
Demo brand, Inc. · Unapproved New Drugs/Misbranded · dated Sep 25, 2026
9working days left · due Oct 16
8Quoted claims ruled
6Critical
1Same claim found in your other copy
Every claim the letter quotes, with the corrective action
Critical
“DemoNerve Nerve Support, 60 capsules: delivers key nutrients to damaged and inflamed nerves.”
The product title itself promises help for damaged and inflamed nerves, so every place the title runs carries a treatment claim.
→ Rename the product title, since the title itself makes the treatment claim.
Standard: Product name implying treatment
Critical
“Formulated for damaged and inflamed nerves.”
Describing nerves as damaged and inflamed names a disease state in a bullet, which can trigger Amazon suppression and treatment as a drug claim.
→ Remove disease terms from title, bullets, A+ content, and backend keywords.
Standard: Disease keyword in Amazon title/bullets
High
“Users felt the difference within 7 days.”
A time-to-result claim needs finished-product trial data supporting the exact 7-day timeframe.
→ Remove unless a trial supports the exact timeframe.
Standard: works in a set number of days
High
“In a study, DemoNerve users reported a significant drop in pain scores after 7 days.”
A study reporting lower pain scores reads as a treatment result, the kind of study run in people with neuropathy.
→ Cite studies in healthy populations, or remove the citation.
Standard: Ingredient study on a disease population
Critical
“DemoNerve goes after the root cause of nerve pain in the feet, hands, arms, legs, head and neck.”
Claiming to target the cause of pain is an explicit drug function claim.
→ Replace with “Provides B vitamins that support normal nerve function.”
Standard: analgesic / pain reliever / relieves pain
Critical
“Relief support for burning, tingling and numbness.”
Burning, tingling and numbness are symptoms of neuropathy, and addressing them is a drug claim.
→ Remove.
Standard: relieves symptoms of
Critical
“Nourishes damaged, struggling nerves.”
'Damaged nerves' names a pathological state rather than a normal structure/function.
→ Replace with “Supports healthy nerve function.”
Standard: Disease keyword in Amazon title/bullets
Critical
“Alpha lipoic acid shields your nerves from damage.”
Shielding nerves from damage is a disease prevention claim.
→ Replace with “Alpha lipoic acid is an antioxidant that supports healthy nerve cells.”
Standard: prevents
Ask about a claim
Paste a line you want to publish. It is ruled against the same 109 standards as your audit, with the rule cited, and failing lines come back with rewrites checked again. Answers usually arrive within a few minutes. A licensed pharmacist reviews any answer on request.
Answers come from AI software. The pharmacist does not review an answer unless you ask for that in your file.
Every question on this file, oldest first
You asked · Oct 5, 10:56 · answered Oct 5, 10:58
AllowedAI only“Our ashwagandha gummies support restful sleep”
Allowed
No findings · 109 standards
Keep the FDA disclaimer wherever this runs as a structure/function claim.
This answer comes from AI software. The pharmacist does not review it unless you ask for that in your file.
Instant ruling · unsigned
You asked · Oct 5, 13:56 · answered Oct 5, 13:58
Needs changesPharmacist-reviewed“Can we say our formula balances cortisol and reduces anxiety?”
Critical
treats anxiety / for anxiety · CV-NC-01
Anxiety is a named condition. Claiming to reduce it is a disease claim.
Rule source: 21 CFR 101.93(g) · FDCA s.201(g)(1)(B)
High
balances hormones · CV-ID-08
"Balance" implies correcting a pathological imbalance.
Rule source: 21 CFR 101.93(g)
Options within the rules, each checked again
Safest
Helps the body adapt to occasional stress.
Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · checked again: no findings
Balanced
Promotes a sense of calm and helps the body adapt to occasional stress.
Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · checked again: no findings
Strongest allowed
Supports healthy cortisol levels already within the normal range and promotes a sense of calm.
Amazon listing · Label (with the FDA disclaimer) · Website · Ads · Email · checked again: no findings
This answer came from AI software and was then reviewed by the pharmacist.
Signed by the licensed pharmacist · Oct 5Reviewer note: Use the safest option on the label.
Findings and fixes
8 findings quoted in the letter, each with its corrective action.
CriticalCV-IC-02
“DemoNerve Nerve Support, 60 capsules: delivers key nutrients to damaged and inflamed nerves.”
→ Rename the product title, since the title itself makes the treatment claim.
The product title itself promises help for damaged and inflamed nerves, so every place the title runs carries a treatment claim. Can lead to: FDA: a warning letter treating it as a drug claim.
Rule source: 21 CFR 101.93(g)
CriticalCV-PP-08
“Formulated for damaged and inflamed nerves.”
→ Remove disease terms from title, bullets, A+ content, and backend keywords.
Describing nerves as damaged and inflamed names a disease state in a bullet, which can trigger Amazon suppression and treatment as a drug claim. Can lead to: FDA: a warning letter treating it as a drug claim, Amazon: listing suppression.
Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
HighCV-SB-03
“Users felt the difference within 7 days.”
→ Remove unless a trial supports the exact timeframe.
A time-to-result claim needs finished-product trial data supporting the exact 7-day timeframe. Can lead to: FTC: a demand for the substantiation, Competition Bureau: a misleading-advertising complaint, Ad Standards Canada: a complaint, Walmart: listing removal.
Rule source: FTC Act s.5(a), 15 U.S.C. 45(a)
HighCV-IC-03
“In a study, DemoNerve users reported a significant drop in pain scores after 7 days.”
→ Cite studies in healthy populations, or remove the citation.
A study reporting lower pain scores reads as a treatment result, the kind of study run in people with neuropathy. Can lead to: FDA: a warning letter treating it as a drug claim, FTC: a demand for the substantiation.
CriticalCV-ID-05
“DemoNerve goes after the root cause of nerve pain in the feet, hands, arms, legs, head and neck.”
→ “Provides B vitamins that support normal nerve function.”
Claiming to target the cause of pain is an explicit drug function claim. Can lead to: FDA: a warning letter treating it as a drug claim.
Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
CriticalCV-DV-09
“Relief support for burning, tingling and numbness.”
→ Remove.
Burning, tingling and numbness are symptoms of neuropathy, and addressing them is a drug claim. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
CriticalCV-PP-08
“Nourishes damaged, struggling nerves.”
→ “Supports healthy nerve function.”
'Damaged nerves' names a pathological state rather than a normal structure/function. Can lead to: FDA: a warning letter treating it as a drug claim, Amazon: listing suppression.
Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
CriticalCV-DV-03
“Alpha lipoic acid shields your nerves from damage.”
→ “Alpha lipoic acid is an antioxidant that supports healthy nerve cells.”
Shielding nerves from damage is a disease prevention claim. Can lead to: FDA: a warning letter treating it as a drug claim, Health Canada: a Schedule A advertising finding, Amazon: listing suppression.
Rule source: FDCA s.201(g)(1)(B), 21 U.S.C. 321(g)(1)(B)
Claims section for counsel
The claims review and replacement wording, signed by the pharmacist, for your counsel to use in the response.
Claims section for counselCurrent
client_report_demo_brand_warning_letter.pdf · signed Oct 4, 2026
Open the sample →
Claim memory
Every line a pharmacist has cleared for Demo brand, kept here to reuse across new ads and listings.
Copy any line. Structure/function lines carry the FDA disclaimer wherever they run.
Provides B vitamins that support normal nerve function.
Listing · Label (with the FDA disclaimer) · Website · Ads · Email
Signed
Supports healthy nerve function.
Listing · Label (with the FDA disclaimer) · Website · Ads · Email
Signed
Alpha lipoic acid is an antioxidant that supports healthy nerve cells.
Listing · Label (with the FDA disclaimer) · Website · Ads · Email
Signed
AI answers
What 6 assistants tell a shopper who asks about Demo brand: ChatGPT, Claude, Gemini, Perplexity, Grok, Alexa for Shopping. Alexa for Shopping (formerly Rufus) is Amazon’s own AI reading your listing to shoppers.
HighFixed
“ChatGPT: "It is known to boost immunity and help fight off colds."”
Repeated a cold claim your audit removed, drawn from an old product page that was still live. The page was taken down and ChatGPT re-tested on Oct 1.
→ Now: “It is marketed as supporting healthy immune function.”
MediumFlagged
“Alexa for Shopping: "Customers say it is clinically proven."”
Drawn from a customer review, not your copy. It is not a claim you made, so it is flagged for you to watch rather than fixed.
Category rank
Risk rank among 194 top-selling Immune listings. 1 is riskiest.
DEMO-LISTING · Immune support supplement, 90 capsules
Scanned 2026-09-25
#11
Riskiest 6% of the category
Label and licence checks
We check your listing against your own label on file with the NIH, rule the claims printed on it, and for Canadian products compare your copy with what your Health Canada licence allows.
US label check: matched your label on file with the NIH Dietary Supplement Label Database. Every amount on the listing appears on the Supplement Facts panel. Front and back panel claims ruled with the audit.
Canada licence check: not run. No NPN was supplied for this product. With one, every sentence of your copy is compared with the purpose your Health Canada licence allows.
Not runChange history
Every step on your file, dated. Every ruling in it carries the standards version it was made under.
Oct 5PharmacistAnswer signed by the pharmacist
Oct 5YouAsked about: “Can we say our formula balances cortisol…”
Oct 5YouAsked about: “Our ashwagandha gummies support restful sleep”
Oct 4PharmacistClaims section signed by the pharmacist and sent to counsel
Oct 3EngineEvery quoted claim ruled, and other copy swept for the same claims
Oct 2YouUploaded warning_letter.pdf
Oct 2YouFile opened